Molecular Subtyping of DCIS: Understanding Breast Cancer Before It Becomes Invasive
Author Information
Author(s): Clark S E, Warwick J, Carpenter R, Bowen R L, Duffy S W, Jones J L
Primary Institution: Centre for Tumour Biology, Institute of Cancer and CR-UK Clinical Centre, Barts and the London School of Medicine and Dentistry
Hypothesis
Can molecular subtypes of invasive breast cancer be identified in ductal carcinoma in situ (DCIS)?
Conclusion
DCIS can be classified similarly to invasive breast cancer, which may help in understanding disease progression.
Supporting Evidence
- Each intrinsic molecular subtype of invasive breast cancer can be identified in DCIS.
- The triple negative and basal-like phenotypes are very uncommon in DCIS.
- Hierarchical clustering analysis identified three main subtypes of DCIS.
Takeaway
This study looked at breast cancer that hasn't spread yet and found that it can be grouped into types just like more advanced cancers, which helps doctors understand how it might develop.
Methodology
The study used tissue microarrays and immunohistochemistry to analyze 188 cases of DCIS for 16 biomarkers.
Potential Biases
Potential bias due to the retrospective nature of the study and missing data.
Limitations
The study faced challenges with tissue sample loss and the heterogeneity of DCIS.
Participant Demographics
The average age of participants was 56 years, with a range from 25 to 85 years.
Statistical Information
P-Value
0.04
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website